Skip to main content

Table 1 Patient’s characteristics

From: Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)

Characteristic

SCLC-A

SCLC-N

SCLC-P

SCLC-I

P value

Gender

 Male

14

11

7

4

 

 Female

7

4

2

4

0.650

Age

 ≥65

7

5

2

2

 

 <65

14

10

7

6

0.949

Smoking status

 Current/former smoker

8

6

8

2

 

 Non-smoker

13

9

1

6

0.031

Tumor location

 Upper or middle lobe

9

8

4

4

 

 Lower lobe

12

7

5

4

0.978

Histology

 Combined

1

1

3

1

 

 Pure

20

14

6

7

0.142

TNM stage

 I-II

16

12

5

7

 

 III

5

3

4

1

0.495

T stage

 T1-2

18

14

6

6

 

 T3

3

1

3

2

0.296

N stage

 N0-1

17

12

6

7

 

 N2

4

3

3

1

0.786

Ki-67 status

 High

5

6

3

3

 

 Low

16

9

6

5

0.743

PD-L1 status

 High

7

2

1

1

 

 Low

14

13

8

7

0.455

CD8 status

 High

9

6

4

2

 

 Low

12

9

5

6

0.864

  1. Abbreviations: SCLC small cell lung cancer, SCLC-A ASCL1-dominant SCLC, SCLC-N NEUROD1-dominant SCLC, SCLC-P POU2F3-dominant SCLC, SCLC-I triple negative or SCLC-inflamed SCLC, TNM tumor-node-metastasis, PD-L1 programmed death-ligand 1